Haku
Viitteet 1-10 / 32
Pharmacy students as agents of medicine education in schools
(Elsevier, 2017)
Introduction: Pharmacy students have since 2014 given medicine education lessons in schools during their internship after the third study year in Finland. Students choose the content of lessons from two modules: for grade ...
Are products with an orphan designation for oncology indications different from products for other rare indications? : A retrospective analysis of European orphan designations granted between 2002-2012
(BioMed Central, 2017-02-16)
Background: Orphan designated medicinal products benefit from regulatory and economic incentives for orphan drug development. Approximately 40% of orphan designations target rare neoplastic disorders, referring to rare ...
Internet as a source of medicines information (MI) among frequent internet users
(Elsevier, 2017-09)
Background: The internet is widely and increasingly used to search for health information. Previous studies have focused mainly on health information on the internet and not specifically on medicines information (MI). ...
Commentary on the MID3 good practices paper
(American Society for Clinical Pharmacology and Therapeutics, 2017-07)
During the last 10 years the European Medicines Agency (EMA) organized a number of workshops on modeling and simulation, working towards greater integration of modeling and simulation (M&S) in the development and regulatory ...
Sairaanhoitaja salapoliisina
(Suomen sairaanhoitajaliitto ry, 2017)
2017 White Paper on recent issues in bioanalysis: rise of hybrid LBA/LCMS immunogenicity assays : Part 3 – LBA: immunogenicity, biomarkers and PK assays
(Future Science, 2017-12-05)
The 2017 11th Workshop on Recent Issues in Bioanalysis (11th WRIB) took place in Los Angeles/Universal City, California on 3–7 April 2017 with participation of close to 750 professionals from pharmaceutical/biopharmaceutical ...
2017 White Paper on recent issues in bioanalysis : A global perspective on immunogenicity guidelines & biomarker assay performance (Part 3-LBA: Immunogenicity, biomarkers and PK assays)
(Future Medicine, 2017)
The 2017 11th Workshop on Recent Issues in Bioanalysis took place in Los Angeles/Universal City, California, on 3-7 April 2017 with participation of close to 750 professionals from pharmaceutical/biopharmaceutical companies, ...
Tavoitteena lääkkeiden määräämisen järkevät käytännöt
(Suomen lääkäriliitto, 2017-11-17)
Preemptive plerixafor injection added to pegfilgrastim after chemotherapy in non-Hodgkin lymphoma patients mobilizing poorly
(Springer - Verlag, 2017-11-01)
Filgrastim is usually combined with chemotherapy to mobilize hematopoietic progenitor cells in non-Hodgkin lymphoma (NHL) patients. Limited information is available on the efficacy of a preemptive plerixafor (PLER) injection ...